Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-11-25 Sale |
2024-11-27 7:09 pm |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
122,628 | $45.96 | $5,635,430 | 454,483 (Direct) |
View |
2024-01-09 Sale |
2024-01-11 8:00 pm |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
5,000 | $25 | $125,000 | 232,567 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-25 Exercise |
2024-11-27 7:09 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
45,000 | $7.38 | 454,483 (Direct) |
View |
2024-11-26 Exercise |
2024-11-27 7:09 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
30,450 | $12.17 | 454,483 (Direct) |
View |
2024-11-25 Exercise |
2024-11-27 7:09 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
45,000 | $8.02 | 454,483 (Direct) |
View |
2024-11-25 Exercise |
2024-11-27 7:09 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
85,000 | $7.8 | 454,483 (Direct) |
View |
2024-11-25 Exercise |
2024-11-27 7:09 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
205,450 | $0 | 454,483 (Direct) |
View |
2024-02-26 Tax Withholding |
2024-02-28 8:00 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
4,282 | $29.53 | 183,285 (Direct) |
View |
2024-01-09 Exercise |
2024-01-11 8:00 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
5,000 | $7.38 | 232,567 (Direct) |
View |
2024-01-09 Exercise |
2024-01-11 8:00 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
5,000 | $0 | 232,567 (Direct) |
View |
2024-01-02 Option Award |
2024-01-04 8:15 pm |
N/A 2034-01-02 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
90,750 | $0 | 259,067 (Direct) |
View |
2023-10-19 Exercise |
2023-10-23 4:31 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
20,000 | $7.38 | 218,317 (Direct) |
View |
2023-10-19 Exercise |
2023-10-23 4:31 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
20,000 | $0 | 218,317 (Direct) |
View |
2023-05-31 Tax Withholding |
2023-06-02 7:51 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
4,150 | $26.07 | 148,037 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 7:51 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
12,000 | $0 | 148,037 (Direct) |
View |
2023-01-16 Option Award |
2023-01-18 7:56 pm |
N/A 2033-01-15 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
144,375 | $0 | 261,937 (Direct) |
View |
2022-04-26 Exercise |
2022-04-26 9:42 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
40,000 | $7.38 | 187,561 (Direct) |
View |
2022-04-26 Exercise |
2022-04-26 9:42 pm |
N/A 2029-01-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
40,000 | $0 | 187,561 (Direct) |
View |
2022-02-28 Tax Withholding |
2022-03-02 8:40 pm |
N/A N/A |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
649 | $24.28 | 77,007 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 7:24 pm |
N/A 2032-02-14 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
87,500 | $0 | 152,656 (Direct) |
View |
2021-02-26 Option Award |
2021-02-26 6:27 pm |
N/A 2031-02-25 |
Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer |
92,000 | $0 | 143,987 (Direct) |
View |